Q2 2022

Filed Aug 1, 2022 · 10-Q · 32 days after period end · 0001493152-22-020890

Q2 2022 · 10-Q

Revenue—

Net Income

-$1.04M

N/M vs Q2 2021

EPS Diluted

$0.00

— vs Q2 2021

Operating Income-$536,667N/M

Operating Cash Flowderived-$480,818N/M

Same quarter

Metric	Q2 2022	Q2 2021	Q2 2020	Q2 2019
Revenue	—	$0.00	$0.00	$0.00
Net Income	-$1.04M	-$2.75M	-$568.80K	-$402.50K
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR